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SUMMARY - Carotid disease is a known risk factor for stroke and stroke is a known risk
factor for cognitive impairment, but relation between carotid artery stenosis and cognitive function
in asymptomatic individuals is less clear. Most patients have only minor complaints of cognitive
dysfunction and assessment with usual tests is not sensitive enough. The study included 26 stro-
ke-free patients (15 male and 11 female), mean age 66.3±8.7 years, with advanced internal carotid
artery stenosis orland occlusion (ICAs/o). Left lCAs/o was present in 11, right lCAs/o in eight,
and bilateral lCAs/o in seven patients. History was taken and assessment of risk factors, brain CT
scan and neurologic examination were performed. Cognitive functions were tested by use of Mini
Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA). All patients
were asymptomatic, except for two patients that presented with repeated transient ischemic attack
(TIA). In all subjects median MMSE scores were within the normal range (27.5; IQrange 25-29),
while mean MoCA scores were abnormal (22.6±3.4). Patients with left lCAs/o scored slightly better
on MaCA (22.9±3.3) than patients with right ICAs/o (22.4±4.0). Delayed recall MaCA subtest
was impaired in 22/26 patients and visuospatial subtest in 23/26 patients; however, there was no
statistically significant difference according to the side ofICAs/o. Patients with the presence ofone
or two risk factors scored lower on visuospatiallexecutive MoCA subtests (P=O.018) as compared
with patients with multiple risk factors. MoCA proved to be a sensitive tool for assessment of mild
cognitive changes in stroke-free patients with advanced lCAs/o. Decline was most pronounced in
visuospatial, executive and short-memory functions.
Key words: Cerebrovascular disorders - etiology; Cerebrovascular circulation ~ physiology; Carotid
stenosis - complications; Cognitive disorders -physiopathology
Introduction
The incidence of carotid disease increases with
age. According to some studies, it is present in 75% of
men and 62% ofwomen aged ,,65, with the prevalence
of ,,50% stenosis in this population being 7% in men
and 5% in women'. The most severe consequence of
carotid occlusive disease is ischemic stroke, which is
also recognized as a risk factor for dementiae'. Stud-
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ies report that up to 30% of all ischemic strokes oc-
cur due to the carotid occlusive disease". On the other
hand, the majority of carotid stenoses are classified as
asymptomatic, implying the absence of stroke (reti-
nal or focal cerebral dysfunction in the territory of the
affected internal carotid artery) symptoms. However,
patients with carotid stenoses often experience cogni-
tive problems which are mostly subtle and not severe
enough to interfere with daily activities. These subtle
cognitive changes can eventually lead to mild cogni-
tive decline as a premonitory state of dementia. The
established risk factors such as arterial hypertension,
hyperlipoproteinemia or diabetes mellitus are recog-
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nized to have measurable adverse effects in the etiol-
ogy of cognitive impairment of vascular type5-13 The
association of vascular risk factors and carotid artery
disease is also well known, but when carotid stenosis
or occlusion is categorized as symptomatic or asymp-
tomatic, cognitive status of the patient is routinely
not taken into consideration". In addition, progres-
sive cognitive decline in patients with cerebrovascu-
lar stenosis may be an even greater problem than the
actual stroke, but it is still not a widely recognized
symptom".
Only a few studies of cognitive status, all of
which included a small number of patients (less than
20) were conducted in patients with a dvanced ca-
rotid stenosis or occlusion'-:". Patients with carotid
stenoses have been shown to have significantly poorer
scores on cognitive tests than matched control sub-
jects. Some cognitive status analyses were performed
regarding the side of carotid disease as well as hemi-
spheric dominance, but common limitations of those
studies were small numbers of patients included, vari-
able definitions of internal carotid artery stenosis and
inconsistent neuropsychological tests used16,20.
Previous studies mostly used the Mini Mental
State Examination (MMSE) as a routine cognitive
measure, whereas in others more complex neurop-
sychological test batteries were employed to analyze
cognitive domains15,16,20,21. Neuropsychological test-
ing with standardized tests often presents a problem
for clinician due to its complicated and time-consum-
ing nature. Although still the most widely used in
the assessment of patients with memory complaints,
MMSE lacks sensitivity in detecting subtle cognitive
changes or early stages of dementia, especially of vas-
cular type". Most individuals meeting clinical crite-
ria for mild cognitive impairment (MCI) score above
26 points on MMSE, which is also normal range for
elderly individuals. Another problem with MMSE
is that it is unable to distinguish between cognitive
functions, so it is not suitable for deeper analysis". The
Montreal Cognitive Assessment (MaCA) developed
by Nasreddine et al. is an easily administered and brief
screening tool with high sensitivity and specificity for
subtle cognitive decline". While MMSE is superior
for more advanced stages of cognitive decline, MaCA
is useful for the mild stages of cognitive impairment
and for distinguishing patients with MCI from cog-
nitively intact patients, which makes it a practical tool
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for first line physicians". A growing number of recent
studies support the use ofMaCA as a valuable screen-
ing tool in the assessment ofcognition in patients with
different neurologic disorders25-28. Some of the MaCA
sub tests have also been proposed for routine use in a
five-minute protocol aiming to assess cognitive de-
cline in individuals with possible vascular cognitive
impairment".
In this pilot study, MMSE and MaCA were used
to assess cognitive changes in stroke-free patients with
advanced carotid stenosis or occlusion.
Patients and Methods
Study participants were recruited from the Uni-
versity Department of Neurology, Sestre milosrdnice
University Hospital in Zagreb. Twenty-seven consec-
utive patients who were referred to the Cerebrovas-
cular Laboratory as outpatients for ultrasound assess-
ment of carotid arteries were initially included in the
study. All patients were diagnosed with advanced in-
ternal carotid artery (ICA) stenosis (more than 70%)
or occlusion (ICAs/o). Such criteria were used for the
known repercussions of ICAs/o on intracranial he-
modynamics. All patients were asymptomatic except
for two patients that presented with repeated tran-
sient ischemic attacks (TIA) and were enrolled in the
study. Five out of 27 patients reported minor subjec-
tive cognitive problems, but others had no subjective
or objective memory complaints prior to enrolment.
Our study was restricted to right-handed patients.
Patients were selected as right-handed if they were
observed to write with their right hand and if they
reported using their right hand to throw a ball and to
brush their teeth.
Color doppler flow imaging (CDFI) of carotid
arteries was also performed in all subjects on admis-
sion. CDFI measurement was done on commercially
available equipment (Aloka Prosound SSD-550 and
Aloka Alfa 10) with linear 10-MHz transducer. Stan-
dard CDFI of both common carotid arteries (CCA),
ICA and external carotid arteries (ECA) was per-
formed according to the defined diagnostic protocol".
Advanced carotid stenosis or occlusion was assessed
according to the predefined criteria and previously de-
scribed procedure". In all patients history was taken
and data on conventional vascular risk factors were
noted, including data on age and sex, arterial hyper-
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tension, diabetes, hyperlipoproteinemia, previous or
current cigarette smoking, and obesity (body mass
index, BMI >25). As part of the neurologic diagnos-
tic procedures, all patients underwent brain computed
tomography (CT) scan within two weeks of enrol-
ment, using Siemens-Sensation Multislice Computed
Tomography scanner with 16-row detector layer, ac-
cording to standard protocol (unenhanced scans with
l-mm slice thickness). Brain CT findings were clas-
sified as positive if the signs of ischemic stroke were
present. One patient was diagnosed with ischemic
stroke at the time of the study and was subsequent-
ly excluded. For the study, results in 26 patients (15
male and 11 female), mean age 66.3±8.7 (range 43-78)
years, were analyzed. Of the 26 patients, 14 had left
ICAs/o (12 with ICA stenosis and 2 with ICA occlu-
sions), 8 had right ICAs/o (all stenosis) and 4 patients
had bilateral ICAs/o (3 patients with left ICA stenosis
also had the right ICA occlusion).
After giving their informed consent, all patients
were tested usingstandardMMSE and Montreal Cog-
nitive Assessment (MoCA)'!·2'. MMSE requires 5-10
minutes for administration. It is composed of items
assessing orientation, immediate and delayed recall
of three words, naming, phrase repetition, the abil-
ity to follow simple commands, writing, visuospatial
function, attention and mental control. Total MMSE
score of 25-30 is considered normal, while scores be-
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low 24 points indicate dementia". MoCA was trans-
lated to Croatian and was administered according to
administration and scoring instructions given by the
authors". It is a 30-point test that takes approximately
30 minutes to administer. The short-term memory re-
call task (5 points) includes two learning trials of five
nouns and delayed recall after approximately 5 min-
utes. Visuospatial abilities are assessed using a clock-
drawing task (3 points) and a three-dimensional cube
copy (1 point). Multiple aspects of executive functions
are assessed using an alteration task adapted from
the Trial Making B task (1 point), a phonemic flu-
ency task (1 point), and a two-item verbal abstraction
task (2 points). Attention, concentration and work-
ing memory are evaluated using a sustained alteration
task (target detection using tapping, 1 point), a se-
rial subtraction task (3 points) and digits forward and
backward (1 point each). Language is assessed using
a three-item confrontation naming task with low-fa-
miliarity animals (lion, camel, rhinoceros; 3 points),
repetition of two syntactically complex sentences (2
points) and the aforementioned fluency task. Finally,
orientation to time and place is evaluated (6 points)".
For MMSE, patients scoring 524 points were consid-
ered as cognitively impaired; cut-off score for MaCA
was 526 points. In order to evaluate the pattern of
cognitive impairment, besides total MoCA scores,
sub test scores for different cognitive domains included
Table 1. Demographic data including risk[actorprofile
All patients
lCA stenosis or occlusion
Left Right Bilateral
n 26 11 8 7
Age (yrs) (mean ± SD) 66.3±8.7 62.6±8.7 68.6±7.5 74.3±3.3
Female (n) 11 6 3 2
Arterial hypertension (n) 22 11 7 4
H )perlipoproteinemia
(total cholesterol>5.0 mmollL
16 8 4 4
or statin
treatment (n)
Diabetes mellitus (n) 13 6 5 2
Smokers (n) 7 3 3 1
Ex-smokers (n) 8 4 3 1
Obesity (BMI >25) (n) 2 1 1 0
Multiple RF (>2) (n) 16 9 4 3
BM! = body mass index; RF = risk factor
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Table 2. Results if cognitive assessment by use if total Mini Mental State Examination
(MMSE) and Montreal Cognitive Assessment (MoCA) scores
MMSE





















'Kruskal-Wallis (ANOVA on ranks); "O ne Way ANOVA
in the MaCA subtests were calculated separately for
each patient.
Prior to any further analysis, all data sets were
analyzed for normality using Kolmogorov-Smirnov
test, and are presented as median ± interquartile range
(IQ) for data that were not normally distributed and
mean ± standard deviation for data that were normally
distributed. Normally distributed data sets were ana-
lyzed using Student's t-test. Not-normally distributed
data sets were analyzed using parametric One Way
Analysis of Variance on Ranks (ANOVA on Ranks),
Mann-Whitney Rank Sum Test, post hoc analysis
was performed using all pair-wise multiple compari-
son procedures (Holm-Sidak method). Difference was
considered to be statistically significant at P<O.OOl.
All statistical procedures were done using the Sig-
maStat 3.0, SPSS Inc. statistical software.
Results
Basic demographic variables and vascular risk fac-
tor profile of patients with ICAs/o according to the
International and National Stroke Association (NSA)
Stroke Prevention Guidelines, along with recordings
of multiple risk factors in patients with left, right and
bilateral ICAs/oJl are presented in Table l.
According to the vascular risk profile, arterial hy-
pertension (AH) was present in 22, hyperlipidemia
in 16 and diabetes in 13 patients. Multiple vascular
risk factors (>2) were noted in 16 patients. Risk factor
profile was similar in subgroups of patients with right,
left or bilateral ICA s/o.
Cognitive results assessed by MMSE and MaCA.
For all patients with ICAs/o (median 27.5; 10..25-29),
as well as for subgroups of patients with left (median
28; 10..25-29) or right (median 27; 10..26-29.5) ICAs/o,
Table 3. Prevalence ifcognition impairment as assessed by Mini Mental State Examination (MMSE) and Montreal
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Table 4. Cognitive scores assessed by Mini Mental State Examination (MMSE), Montreal Cognitive Assessment
(MoCA) andMoCA cognitive domains subtests in patients with lift, right and bilateral carotid stenosisor occlusion (one
wayANOVA, Kruskal-WallisANOVA on ranks)
Carotid stenosis or occlusion
Left Right Bilateral
n 11 8 7
F (n) 6 3 2
Age (yrS)l 62.8±8.6 68.6±7.5 69.0±9.4
MMSE2 28 (25.8-29.0) 27 (26-29.5) 26 (25-27.5)
MaCA 1 22.9±3.3 22.4±4.0 22.6±3.3
M
- visuospatial/executive- 3.5±1.5 3.0±1.0 3.3±1.4
- naming; 3 (3-3) 3 (3-3) 3 (3-3)
- attention? 5 (3.5-6) 5.5 (4-6) 6 (4-6)
- language' 2 (2-2) 2 (2-2.5) 2 (2-2.8)
- abstraction" 1 (1-1.8) 1 (1-2) 1 (1-2)
- delayed recall- 2 (1.3-4.5) 0.5 (0-3.5) 0(0-2.5)












'mean ± SD; -medtan (25-75 percentile,range); 'Kruskal-W allts (ANOVA on ranks); "O ne Way ANOVA
MMSE scores fell within the normal range. In pa-
tients with bilateral ICAs/o, the mean MMSE scores
were slightly below the normal range (mean 25.5±2.6),
although this subgroup of patients was represented
with a small sample. The mean MaCA scores were
below the normal range in all patients with ICAs/o.
Patient subgroups with left, right or bilateral ICAs/o
also scored below the normal range on MaCA, with
lowest score (mean 21.5±3.7) recorded in the subgroup
of patients with bilateral ICAs/o. Neither MMSE nor
MaCA results showed any statistically significant dif-
ferences in cognitive scores among patient subgroups
according to the side oflCAs/o. Total cognitive scores
are presented in Table 2.





Age (yrs)" 62.3±9.3 67.9±7.8
MMSE' 28.5 (22-39) 26.5 (25-28)
MaCA" 23.25±3.5 21.7±3.2
- visuospatial/executive 4 (3-5) 3 (2-3)
-e naming" 3 (3-3) 3 (3-3)
- attention' 6 (4-6) 5 (4-6)
-language 2 (2-2) 2 (2-2)
- abstraction 1(1-1.5) 1.5 (1-2)
- delayed recall 2.13±2.0 1.5±1.7
















= one or two risk fac-
tors; 'median ± interquartile range, Mann-Whitney Rank Sum Test; "mean ± SD, t-test; " statistically significant difference
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Cognitive scores below normal range presented as
MMSE and MaCA results and MaCA subtests scores
are summarized in Table 3. MMSE was abnormal in
9 of 26 patients, while total MaCA score was below
the normal range in all but two patients. When MaCA
was used, most patients from all subgroups were found
to have a cognitive decline (13 of 14 in patient subgroup
with left ICAs/o; 7 of 8 in patient subgroup with right
ICAs/o; and 2 of 4 in patient subgroup with bilateral
ICAs/o). The most pronounced decline was found in
delayed recall and language (22 of 26 patients) and
visuospatiallexecutive functions (21 of 26 patients).
There were no statistically significant differences in
cognitive domain scores among the subgroups of pa~
tients with right, left or bilateral ICAs/o when MaCA
subtests were used for cognitive evaluation (Table 4).
Cognitive testing scores and vascular risk factor
profile. In order to evaluate the possibility of the as-
sociation between carotid stenosis or occlusion and
cognitive performance to be modified by the pres-
ence of vascular risk factors, the risk factor profile was
noted and subtest scores for cognitive domains were
included in MaCA subtests calculated for all patients.
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Cognitive testing scores in the subgroups of patients
with more than 2 and with only 1 or 2 risk factors
are summarized in Table 5. Comparison of MMSE
and MaCA scores between patients with and without
multiple risk factors (MRF) yielded no statistically
significant differences between the subgroups, except
for the visuospatiallexecutive subtest (P=0.022).
Cognitive scores were also analyzed separately for
subgroups of patients with only 1 or 2 risk factors,
subgroups of patients with MRF including arterial
hypertension, and subgroups of patients with MRF
including arterial hypertension, hyperlipidemia and
diabetes. There were no statistically significant differ-
ences among these groups, except for the visuospatiall
executive subtest (P=0.018) (Table 6).
Discussion
Our results showed subtle cognitive impair-
ment as assessed by MaCA in stroke-free patients
with advanced carotid disease. Cognitive status of
the patients with carotid disease has been observed
in some previous studies, which mostly assessed
Table 6. Dijfirences in cognitive testing scores in subgroups ifpatients withoutpresence ifmultiple riskfactors (RF -::'2),
patients with multiple riskfactors including arterial hypertension 01RF (+AH)] andpatients with multiple riskfactors
including arterial hypertension, hyperlipidemia and diabetes01RF (+AH, HLP,DM)]
Risk factors
RF52 MRF (+AH) MRF (+AH, HLP, DM)
n 10 11 14
F 6 6 7
Age (yrS)1 67.9±7.8 65.2±9.9 66.9±7.6
MMSE 26.5(25-28)2 27.6±2.4' 27.0±2.3 '
MoCN 21.7±3.2 23.4±3.1 22.5±2.6
- visuospatial/executive 2.6±1.7' 4(3-5)' 4(3-5)'
- naming- 3(3-3) 3(3-3) 3(3-3)
- attention 4.6±1.4' 6(4-6)2 5(4-6)2
-language2 2(2-2) 2(2-2) 2(1.3-2)
- abstraction- 1.5(1-2) 1(1-2) 1(1-1)
- delayed recall 1.5±1.7' 2(0-4)2 2(0-3)2












'mean ± SD; -rnedtan (25-75 percentile, range); "statistically significant difference; 'Kruskal-W allts (ANOVA on ranks);
"O ne Way ANOVA
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cognItive decline in pat ients wit h symptomat ic ca-
rotid disease (i.e. previous stroke or T IA) and /or in
symptomatic ICA stenosis patients before scheduled
carotid endarterectomy3,15,16,33-38. Cognit ive assess-
ment of asymptomatic patients with carotid disease
has so far been investigated in a smaller numb er of
studies16,18.2Q.36,39.
W hether carotid stenosis itself causes or con-
tributes to cognitive impairment in patients that are
otherwise asymptomatic has not yet been clarified" .
Ca rotid artery disease is associated with underlying
vascular risk factors. The same vascular risk factors
are well known to increase the risk of ischemic injury
to the brain independently of caro tid disease" . Fur-
thermore, several risk factors for vascular disease are
strongly associated with cognitive impairment 2,3,5-8.
In our study, M MS E scores showed no signs of
cognitive impairment in patients with ICAs/o, either
in the subgroup of patients with left ICAs/o or those
with right ICAs/o . Slightly abnormal MMS E scores
were only found in patients with bilateral lCAs/o
(mean ± SD: 25.5±2.6), although thi s subgroup of pa-
tients was represented with a small sample. The mean
M oCA scores were below th e normal range in all pa-
tients with ICAs/o and in all subgroups of patients
divided according to the side of stenosis. Patients
with bilateral ICAs/o that were found to suffer from
slight cognitive impairment when tested by MMSE,
also had the lowest total M oCA score (mean ± SD:
21.5±3.7). This finding corroborates the superior abili-
ty of MoCA to detect very mild cognitive distu rbanc-
es, as previously demonstrated elsewhere" ·" . MMSE
is still the most commonly applied cognitive screening
tool. M oCA has been shown to be a rapid and reli-
able cognitive screening instrument that is sensitive
enough to detect mild cognitive deficits" ," . Both tests
are easy and convenient to administer, but MMS E is
subjec t to criticism mostly because it fails to discrimi-
nate exactly betwee n individuals with dementia and
those that are non-demented, and has overly simple
language items that reduce its sensitivity to mild lin-
guistic deficits" ·40
The analysis of M oCA subtest scores for different
cognitive domains revealed our patients with ICAs/o
to have cognitive decline most often when tested for
visuospatiallexecutive funct ions (21 of 26 pat ients)
and for short-term memory and language functions
as assessed by delayed recall task and verbal fluency
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test (22 of26 patients). Executive funct ions on M oCA
are tested using Tria l M aking Test B and visuospatial
abilities using clock drawing test and three dimen-
sional cube copy, which all are known to be sensitive to
frontal lobe dysfunction. In M oCA, short-term mem-
ory and language funct ions are assessed by delayed re-
call task and by verbal fluency test. Besides temporal
lobe disturbances, these tests also assess involvement
of the fronta l lobe areas. A similar patt ern of cognitive
impairment with signs of frontal lobe dysfunction in
pat ients with carotid stenosis was found in some pre-
vious studies, although some of them included larger
patient samples. In a study of 83 parients with asymp-
tomatic severe caro tid stenosis, Silvestrini e/ al. found
Significantly lower per formance at verbal fluency test
in pat ients with left-sided disease as compared with
controls and other groups of stenosis". Rao showed
impaired frontal lobe funct ions as assessed by verbal
fluency test in patients with asymptomatic ICAsfo!6,
whereas Benke et aI., in a study of 20 patients with
asymptomatic carotid stenosis found substantial defi-
cits on verbal processing tasks, as well as on mental
speed, learning, visuospatial abilities and deductive
rcasonmg' <" . In a larger sample of 183 patients wi th
different grad es of carotid stenosis from the Tromse
study, Mathiesen et al. foun d att ent ion, psychomo-
tor speed and memory to be significantly lower when
compared to controls without carotid stenosis". The
same pattern of cognitive impairment was recognized
as typical for vascular cognitive impairment. It may
include all cognitive domains, but there is likely to
be a preponderance of execut ive dysfunction includ-
ing working memory". The most common problems
when comparing study results are different sample
size and inclusion/exclusion criteria. Non-uniformed
neuropsychological testing protocols often present an
additional problem.
We found no statistically significant differences in
cognitive domain scoresamong patient subgroupswith
right, left or bilateral ICAsto when MoCA subtests
were used for cognitive evaluation. In a study that in-
cluded a similar patient sample (32 patients, of which
only 27 had unil ateral stenosis), ]o hnston et al. found a
higher prevalence of impaired cognition on modified
MMSE in patients with severe stenosis of the left ICA
as compared to the right ICA stenosis". We believe
that the size of our sample was probably insufficient
to detect a difference in the laterality of stenosis. We
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have previously shown an increased incidence of mild
cognitive decline in symptom-free individuals with
the presence of vascular risk factors-". Accordingly,
the management of vascular risk factors and lifestyle
adjustments may help prevent both Alzheimers dis-
ease (AD) and vascular dementia (VAD)42,43 In the
present study, only visuospatiallexecutive subtests of
MoCA yielded significant differences when patients
with and without MRF were compared (P=G.G22).
Comparison of subgroups of patients with MRF that
included only arterial hypertension and subgroups of
patients with MRF that included three most common
risk factors (arterial hypertension, hyperlipidemia and
diabetes) again revealed significant differences in visu-
ospatiallexecutive subtests ofMoCA (P=G.G18). Most
of our patients had no subjective memory complaints,
so our results agree with the aforementioned reports
that have stressed the preponderance ofexecutive dys-
function in the initial cognitive decline of vascular
type". Paradoxically, in our study patients with only
one or two risk factors had lower cognitive scores than
patients with MRF (Tables 5 and 6). This may have
also been due to the small sample size or the lack of
compliance in the management ofvascular risk factors
and lifestyle adjustments, which is often a problem in
this patient group.
Our study had limitations since the overall num-
ber of patients was small, but statistical significance
was achieved. There are no previous studies that in-
vestigated the ability of MoCA in patients with ca-
rotid disease. We did not speculate on the possible
pathomechanisms of cognitive impairment in patients
with severe carotid disease, which remain quite ob-
scure. The mechanisms proposed include silent em-
bolization and hypoperfusion, and Silvestrini et a/.
also consider altered cerebrovascular reactivity to be
responsible for cognitive decline in patients with as-
ymptomatic carotid stenosis":".
Although performed in a small patient sample, our
study further implicates that the presence of multiple
vascular risk factors could possibly aid to the cognitive
decline in patients with severe carotid disease, espe-
cially considering executive and visuospatial domains.
It also further stressed the importance of tight con-
trol of vascular risk factors in both symptomatic and
asymptomatic patients with severe carotid disease":".
Stroke-free patients with advanced carotid stenosis
or occlusion express subtle cognitive impairment es-
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pecially in visuospatial and executive domains. Such
cognitive changes can be easily recognized if MoCA
is used for assessment, while MMSE remains too
rough to detect mild cognitive decline and fails to
discriminate among affected cognitive domains more
precisely. We found no differences in cognitive im-
pairment according to the side of ICAs/o, but the ini-
tial cognitive impairment in visuospatial and execu-
tive domains was significantly related to the vascular
risk factor profile.
In order to carefully evaluate cognitive changes in
individuals with severe carotid disease and to reduce
the risk of more severe cognitive decline, additional
studies in a greater number of patients are needed.
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Saietak
PROqENA BLAGOG SPOZNAJNOG POREMECAJA KOD BOLESNIKA S KAROTIDNOM BOLESCU
BEZ MOZDANOG UDARA
L Martinii-Popovic, A. Lourenci/-Huxjan i V Demarin
Karotidna bolest je prepoznata kao cimbenik rizika za nastanak mozdanog udara, a mozdani udar kao cimbenik
rizika za poremecaj spoznajnih funkcija, no povezanost stenoze karotidnih arterija i spoznajnih funkcija je manjc jasna.
Vecina bolesnika navodi sarno blaze spoznajne poteskoce za procjenu kojih uobicajeni testovi nisu dovoljno osjetljivi.
Dvadesetsestoro bolesnika s uznapredovalom stenozom i/ili okluzijom unutarnje karotidne arterije (ICA) je ukljuceno
u ispitivanje (srednje dobi 66,3±8,7 godina, 15 muskaraca i 11 zena), jedanaestoro s lijevostranom, 8 s desnostranom i 7 s
obostranom stenozom ifili okluzijom lCA. Uz anamnesticke podatke i neuroloski pregled kod svih bolesnika zabiljeie-
ni su podaci 0 vaskularnim crmbemcima rizika i ucinjen [e CT mozga. Spoznajne funkcije su ispitane primjenom Mini
Mental testa (MMSE) i Montrealske ljestvice kognitivne procjene (MoCA). Svi bolesnici su bili asimptomatski, osim
dvoje bolesnika koji su imali ponovljene prolazne ishemijske atake (TlA). Kod svih bolesnika vrijednost medijana testa
MMSE bila [e u granicama normale (27,5; lQraspon 25-29), dok su srednje vrijednosti testa MoCA bile snizene u odnosu
na normalne vrijednosti (22,6±3,4). Bolesnici sa stenozom i/ili okluzijom lijeve ACl imali su nesto bolje rezultate na testu
MoCA (22,9±3,3) u odnosu na bolesnike s desnostranom bolescu (22,4±4,O). Kod 22 od 26 bolesnika nadene su sruzene
vrijednosti na MoCA podtestu odgodenog pnsjecanja. a kod 23 od 26 bolesnika sruzene vrijednosti na MoCA podtestu
ispitivanja vidno-prostornih funkcija, no nisu nadene statisticki znacajne razlike u odnosu na stranu stenoze i/ili okluzije
lCA. Rezultati bolesnika s jednrm ili dva vaskularna crmbemka rizika na MoCA podtestu za ispitivanje vidno-prostor-
nih i izvrSnih funkcija bili su su losiji u odnosu na rezultate bolesnika s visestrukim crmbemcima rizika (P=O,018). Test
MoCA ima dovoljnu osjetljivost za procjenu blagog spoznajnog poremecaja kod bolesnika s uznapredovalom stenozom if
ili okluzijom karotidnih arterija, bez mozdanog udara. Najizraieniji poremecaj zabiljeien je u odnosu na vidno-prostorne
funkcije te na kratkorocno pamcenje.
Kljucne rijeci: Cerebrovaskularne bolesti - etiologiJa; Cerebrovaskularni krvotok - jiziologiJa; Karotidna stenoza - komplika-
cije;Spoznajni poremeiaji - patojiziologiJa
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